Inflammatory bowel disease: Is it really just another break in the wall?

Gut

Volumn 56, Issue 1, 2007, Pages 6-8

  Weber, C R ^a   Turner, J R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CROHN DISEASE; DISEASE COURSE; ENTERITIS; HUMAN; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

CELL MEMBRANE PERMEABILITY; COLITIS, ULCERATIVE; CROHN DISEASE; EPITHELIUM; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; INTESTINAL MUCOSA; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MYOSIN-LIGHT-CHAIN KINASE; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845965299     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.104182     Document Type: Review

References (26)

1. Hollander D. Crohn's disease-a permeability disorder of trie tight junction? Gut 1988;29:1621-4.
2. Arnott IDR, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 2000;35:1163-70.
3. Wyatt J, Vogelsang H, Hubl W, et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993;341:1437-9.
4. Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989;97:927-31.
5. Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997;113:802-7.
6. Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudins 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007;56:61-72.
7. Simon DB, Lu Y, Choate KA, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999;285:103-6.
8. Amasheh S, Meiri N, Gitter AH, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002;115:4969-76.
9. Furuse M, Furuse K, Sasaki H, et al. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001;153:263-72.
10. Van Itaillie CM, Fanning AS, Anderson JM. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol 2003;285:F1078-84.
11. Furuse M, Fujita K, Hiiragi T, et al. Claudin-1 and - 2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998;141:1539-50.
12. Sasaki H, Matsui C, Furuse K, et al. Dynamic behavior of paired claudin strands within opposing plasma membranes. Proc Natl Acad Sci USA 2003;100:3971-6.
13. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001;120:411-22.
14. Holmes JL, Van Itallie CM, Rasmussen JE, et al. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 2006;6:581-8.
15. Prasad S, Mingrino R, Kaukinen K, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 2005;85:1139-62.
16. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005;129:550-64.
17. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004;84:282- 91.
18. Zolotarevsky Y, Hecht G, Koutsouris A, et al. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 2002;123:163-72.
19. Ma TY, Boivin MA, Ye D, et al. Mechanism of TNF-a modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005;288:G422-30.
20. Wang F, Graham WV, Wang Y, et al. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005;166:409-19.
21. Wang F, Schwarz BT, Graham WV, et al. IFN-g-induced TNFR2 upregulation is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 2006;131:1153-63.
22. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164-72.
23. Clayburgh DR, Musch MW, Leitges M, et al. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for in vivo TNF-mediated diarrhea. J Clin Invest 2006;116:2682-94.
24. Clayburgh DR, Barrett TA, Tang Y, et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest 2005;115:2702- 15.
25. Graham WV, Wang F, Clayburgh DR, et al. TNF induced long myosin light chain kinase transcription is regulated by differentiation dependent signaling events: characterization of the human long myosin light chain kinase promoter. J Biol Chem 2006;26:9462-70.
26. Blair SA, Kane SV, Clayburgh DR, et al. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 2006;86:191-201.